Trial Profile
Phase III Study to Demonstrate the Efficacy and Safety of RG1068 (Synthetic Human Secretin)- Enhanced Magnetic Resonance Cholangiopancreatography (MRCP) in the Evaluation of Subjects With a History of Acute or Acute Recurrent Pancreatitis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Dec 2014
Price :
$35
*
At a glance
- Drugs Secretin (Primary)
- Indications Pancreatitis
- Focus Diagnostic use
- Sponsors Repligen Corporation
- 05 Dec 2014 New trial record